...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM

"Zenith's 3rd quarter filings (January 31, 2024) are overdue"

I note that Zenith reported the January 31, 2023, (a year ago) interim financial statement on April 6, 2023.

 

Koo

2
Mar 22, 2024 03:46PM
1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply